Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
412,914,375
-
Total 13F shares
-
3,731,679
-
Share change
-
-433,044
-
Total reported value
-
$4,067,948
-
Price per share
-
$1.09
-
Number of holders
-
17
-
Value change
-
-$471,792
-
Number of buys
-
8
-
Number of sells
-
3
Institutional Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q1 2025
As of 31 Mar 2025 Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) had 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,731,679 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, SPHERA FUNDS MANAGEMENT LTD., Yelin Lapidot Holdings Management Ltd., Ikarian Capital, LLC, MORGAN STANLEY, KESTRA PRIVATE WEALTH SERVICES, LLC, Virtu Financial LLC, BOOTHBAY FUND MANAGEMENT, LLC, RHUMBLINE ADVISERS, and TWO SIGMA SECURITIES, LLC.
This table shows 17 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.